Early-Stage NSCLC: Advances in Thoracic Oncology 2018.

Adjuvant therapy immunotherapy neoadjuvant therapy non-surgical treatment screening surgical resection

Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
06 2019
Historique:
received: 07 01 2019
revised: 22 02 2019
accepted: 24 02 2019
pubmed: 10 3 2019
medline: 22 7 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

2018 was a banner year for all thoracic oncology, but especially for early-stage NSCLC. Three seminal events occurred in the approximately 18 months from mid-2017 to the end of 2018: in June 2017 at the American Society of Clinical Oncology Annual Meeting a small, relatively unheralded study from Max Diehn's group at Stanford University reported on the use of a novel "cancer personalized profiling by deep sequencing" circulating tumor-DNA technology to identify minimal residual disease in patients after curative-intent radiation or surgery for NSCLC; in April 2018 at the American Association for Cancer Research Annual Meeting, Drew Pardoll presented a small pilot study of 21 patients who had received two doses of preoperative nivolumab; in September 2018, at the 19th World Conference on Lung Cancer, Harry J. De Koning presented the long-awaited results of the Dutch-Belgian Lung Cancer Screening Trial (NELSON). These three seminal studies, along with others which are reviewed in this paper, promise to accelerate our progress towards a world in which lung cancer is identified early, more patients undergo curative-intent treatment that achieves the promised cure, and those at risk for failure after treatment are identified early, when the cancer remains most vulnerable. The day is around the corner when lung cancer is defanged and no longer the worldwide terror it currently is. We herein present an overview of the most recent body of work that moves us inexorably towards that day.

Identifiants

pubmed: 30851441
pii: S1556-0864(19)30199-6
doi: 10.1016/j.jtho.2019.02.029
pmc: PMC6534444
mid: NIHMS1523358
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

968-978

Subventions

Organisme : NCI NIH HHS
ID : R01 CA172253
Pays : United States

Informations de copyright

Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Références

J Thorac Dis. 2018 Feb;10(2):790-798
pubmed: 29607150
Lancet Oncol. 2015 Jun;16(6):630-7
pubmed: 25981812
J Clin Oncol. 2018 Oct 20;36(30):2995-3006
pubmed: 30106638
J Thorac Dis. 2018 Jan;10(1):458-463
pubmed: 29600078
Lancet. 2016 Sep 3;388(10048):1012-24
pubmed: 27598681
Radiat Oncol. 2017 Jan 27;12(1):30
pubmed: 28129789
Support Care Cancer. 2012 Dec;20(12):3169-77
pubmed: 22526147
Ann Thorac Surg. 2018 Apr;105(4):1050-1057
pubmed: 29502935
Respir Investig. 2014 Nov;52(6):322-9
pubmed: 25453375
Support Care Cancer. 2019 Apr;27(4):1535-1540
pubmed: 30426204
Lung Cancer. 2005 Jul;49(1):25-33
pubmed: 15949587
J Thorac Dis. 2018 Apr;10(4):2240-2248
pubmed: 29850128
J Thorac Dis. 2018 Apr;10(4):2331-2337
pubmed: 29850138
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Eur J Cardiothorac Surg. 2018 Nov 1;54(5):912-919
pubmed: 29718155
J Thorac Cardiovasc Surg. 2018 Feb;155(2):778-786
pubmed: 29031947
Cancer Discov. 2017 Dec;7(12):1394-1403
pubmed: 28899864
Eur J Appl Physiol. 2012 Aug;112(8):3061-8
pubmed: 22194005
Clin Cancer Res. 2016 Jan 15;22(2):273-4
pubmed: 26482042
N Engl J Med. 2018 May 24;378(21):1976-1986
pubmed: 29658848
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
J Thorac Cardiovasc Surg. 2011 Mar;141(3):662-70
pubmed: 21335122
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2746-2754
pubmed: 29548583
Ann Thorac Surg. 2018 Oct;106(4):989-997
pubmed: 29852148
Pract Radiat Oncol. 2018 Mar - Apr;8(2):e71-e78
pubmed: 29291965
Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1141-1148
pubmed: 30012526
J Thorac Cardiovasc Surg. 2018 Jul;156(1):394-402
pubmed: 29709364
JAMA Oncol. 2018 Oct 1;4(10):e182078
pubmed: 30003238
Lancet Oncol. 2017 Dec;18(12):e754-e766
pubmed: 29208441
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
J Cardiothorac Surg. 2018 Aug 24;13(1):91
pubmed: 30143031
N Engl J Med. 2018 May 24;378(21):2034-2035
pubmed: 29791816
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1378-1390
pubmed: 27479723
Innovations (Phila). 2018 Sep/Oct;13(5):338-343
pubmed: 30394958
Health Technol Assess. 2016 May;20(40):1-146
pubmed: 27224642
J Thorac Oncol. 2019 Jan;14(1):107-114
pubmed: 30292851
JAMA Oncol. 2018 Jan 01;4(1):80-87
pubmed: 28973110
J Vasc Interv Radiol. 2018 Sep;29(9):1211-1217.e1
pubmed: 30061058
J Clin Oncol. 2018 Jun 1;36(16):1631-1641
pubmed: 29504847
J Thorac Oncol. 2018 Dec;13(12):1818-1831
pubmed: 30268698
JAMA Oncol. 2017 Nov 01;3(11):1529-1537
pubmed: 28687838
Lancet Respir Med. 2018 Dec;6(12):915-924
pubmed: 30442588
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1224-1227
pubmed: 28345951
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):91-115
pubmed: 30304509
Ann Thorac Surg. 2017 Mar;103(3):956-961
pubmed: 27720368
J Clin Oncol. 2015 Dec 1;33(34):4007-14
pubmed: 26324372
Clin Lung Cancer. 2019 Jan;20(1):e63-e71
pubmed: 30337269
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
J Thorac Oncol. 2016 Jul;11(7):1012-28
pubmed: 27089851
Medicine (Baltimore). 2018 May;97(20):e10461
pubmed: 29768322
Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1173-1179
pubmed: 29377988
Radiology. 2017 Jul;284(1):228-243
pubmed: 28240562
Lancet Oncol. 2018 Jan;19(1):139-148
pubmed: 29174310
Ann Thorac Surg. 2017 Dec;104(6):1805-1814
pubmed: 29102039
Eur J Cardiothorac Surg. 2019 Apr 1;55(4):660-665
pubmed: 30325413
Ann Thorac Surg. 2018 Jul;106(1):272-279
pubmed: 29530770
Expert Rev Respir Med. 2013 Oct;7(5):533-44
pubmed: 24138695
Ann Thorac Surg. 2018 Jul;106(1):228-234
pubmed: 29534956
Ann Oncol. 2018 Aug 1;29(8):1853-1860
pubmed: 29982279
J Thorac Oncol. 2011 Feb;6(2):244-85
pubmed: 21252716
JAMA Oncol. 2018 Sep 1;4(9):1263-1266
pubmed: 29852037
Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):738-747
pubmed: 29413285
Ann Thorac Surg. 2018 Feb;105(2):425-431
pubmed: 29198624
J Thorac Oncol. 2019 Mar;14(3):503-512
pubmed: 30521970
Eur J Cardiothorac Surg. 2017 Jun 1;51(6):1149-1156
pubmed: 28158453
J Clin Oncol. 2019 Jan 10;37(2):97-104
pubmed: 30444685
J Thorac Oncol. 2020 Mar;15(3):344-359
pubmed: 31731014
Lancet. 2017 Oct 21;390(10105):1813-1814
pubmed: 28855076
Clin Rehabil. 2017 Aug;31(8):1057-1067
pubmed: 28730888
Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):186-194
pubmed: 29619964
J Thorac Oncol. 2017 Feb;12(2):323-333
pubmed: 27771425
Ann Thorac Surg. 2018 Sep;106(3):902-908
pubmed: 29704479
Lancet. 2017 Oct 21;390(10105):1833-1842
pubmed: 28855077
J Thorac Oncol. 2017 Jan;12(1):27-35
pubmed: 27642065
J Thorac Oncol. 2015 Jul;10(7):990-1003
pubmed: 26134221
J Thorac Oncol. 2018 Jun;13(6):855-862
pubmed: 29518554

Auteurs

Raymond U Osarogiagbon (RU)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee. Electronic address: rosarogi@bmg.md.

Giulia Veronesi (G)

Division of Thoracic and General Surgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

Wentao Fang (W)

Department of Thoracic Surgery, Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, China.

Simon Ekman (S)

Thoracic Oncology Center, Karolinska University Hospital/Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Kenichi Suda (K)

Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.

Joachim G Aerts (JG)

Thoracic Oncology Department, Erasumus University Medical Center, Rotterdam, Netherlands.

Jessica Donington (J)

Section of Thoracic Surgery, University of Chicago, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH